These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3372704)

  • 1. The response of depressed inpatients to isocarboxazid.
    Davidson J; Lipper S; Pelton S; Miller RD; Hammett EB; Mahorney S; Varia IM
    J Clin Psychopharmacol; 1988 Apr; 8(2):100-7. PubMed ID: 3372704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
    Giller E; Bialos D; Harkness L; Riddle M
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
    Davidson J; Sullivan JL
    J Clin Psychopharmacol; 1983 Feb; 3(1):42-3. PubMed ID: 6833523
    [No Abstract]   [Full Text] [Related]  

  • 6. MAO inhibitor therapy in trichotillomania associated with depression: case report.
    Krishnan RR; Davidson J; Miller R
    J Clin Psychiatry; 1984 Jun; 45(6):267-8. PubMed ID: 6725219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of three discriminant scales for endogenous depression.
    Davidson JR; Pelton S
    Psychiatry Res; 1988 Feb; 23(2):193-200. PubMed ID: 3363027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors in the treatment of atypical depression.
    Zisook S; Braff DL; Click MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):131-7. PubMed ID: 3889078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and anxiety inventories, and the dexamethasone suppression test.
    Sangal R; Correa EI; DePaulo JR
    Biol Psychiatry; 1984 Aug; 19(8):1207-13. PubMed ID: 6498243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the five-factory inventory in characterizing patients with major depressive disorder.
    Petersen T; Bottonari K; Alpert JE; Fava M; Nierenberg AA
    Compr Psychiatry; 2001; 42(6):488-93. PubMed ID: 11704941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic-induced dysphoric response in non-schizophrenic patients].
    Berardi D; Zanfini R; Alessi S; Giannelli A; Ferrari G
    Minerva Psichiatr; 1993 Jun; 34(2):125-33. PubMed ID: 8105358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of self-rated and observer-rated dysphoric symptoms in mania.
    Cassidy F; Ahearn E; Carroll BJ
    J Affect Disord; 2009 Apr; 114(1-3):294-8. PubMed ID: 18684512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
    Sato T; Bottlender R; Kleindienst N; Möller HJ
    J Affect Disord; 2005 Feb; 84(2-3):187-96. PubMed ID: 15708416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.